The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.
Cigna Group reaffirms 2024 EPS outlook, reports strong Q3 results, and clarifies it is not pursuing a merger with Humana amid ...
Cold water has been tossed on the idea that CVS Health would break up the company and sell off health or pharmacy benefits from assets that provide medical care if you listen closely to the company’s ...
Headlines,Assetmark Inc. boosts its stake in CVS Health,Institutional investors continue to increase CVS Health holdings,CVS ...